Pfizer Fiscal Q3 Adjusted Earnings Flat, Revenue Falls; Raises 2026 Guidance

07:02 AM EST, 11/03/2026 (MT Newswires) -- Pfizer (PFE) reported fiscal Q3 adjusted earnings Tuesday of $0.87 per diluted share, unchanged from a year earlier. Analysts polled by FactSet expected $0.74. Revenue for the quarter ended Sept. 27 was $16.58 billion, compared with $16.65 billion a year earlier. Analysts expected $15.85 billion. For 2026, the company now expects adjusted diluted EPS of $2.95 to $3.05, compared with its prior guidance of $2.80 to $3. Analysts are looking for $2.96. Revenue for the full year is expected in the range of $62 billion to $64 billion, compared with its previous guidance of $60.5 billion to $62.5 billion. Analysts are looking for $62.24 billion.